| Literature DB >> 31938644 |
Adamantia Aroni1, Sofia Zyga1, Maria Tsironi1, Demetrios Presvelos2, Anastasios Drakopoulos3, Maria Ralli4, Ioannis Moisoglou5, Vasiliki Leventogianni6, Georgios Kosmidis7, Andrea Paola Rojas Gil1.
Abstract
Aim The advanced glycation end products (AGEs) are among the mechanisms responsible for the pathogenesis and development of chronic kidney disease. The aim of this study was to estimate the dietary AGE intake and to assess its correlation with hematological and biochemical markers of patients with end-stage renal disease (ESRD) undergoing hemodialysis. Materials and methods For this study, a structured questionnaire of the exogenous AGEs was developed, whose reliability and validity were evaluated in the pilot phase of the study including 50 participants. The questionnaire was issued to 605 participants (305 ESRD patients undergoing hemodialysis and 300 controls), and a blood sample was obtained through which hematological and biochemical markers were analyzed. Results It was noted that patients with ESRD consume large quantities of dietary AGEs not only in absolute values but also in comparison with control subjects (p = 0.001), attributed mainly to the methods of product processing as well as cooking. It was also ascertained that dietary AGEs were correlated (p < 0.005) with fasting glucose and glycated hemoglobin (HbA1c) and with lipidemic profile markers, such as triglyceride, as well as inflammation markers, such as erythrocyte sedimentation rate, ferritin, and C-reactive protein. All the aforementioned markers show abnormally increased levels in patients with ERSD and diabetes compared with healthy subjects. Conclusion Patients with ESRD consuming foods favoring AGE formations combined with increased endogenous AGE burden the body with their harmful action. If the specific group of patients adopt dietary habits contributing to the containment or the inhibition of AGE formation, then this would lead to the improvement of their hematological and biochemical markers and in terms of the effects of AGEs on their health is deemed imperative through the creation of consulting and prevention programs.Entities:
Keywords: advanced glycation end products; chronic renal disease; diabetes mellitus; hemodialysis; nutrition
Year: 2019 PMID: 31938644 PMCID: PMC6957054 DOI: 10.7759/cureus.6360
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Demographic data of patients and control subjects
1. Mean ± standard deviation
| Demographic data | Patients (Ν = 305), Ν (%) | Control subjects (Ν = 247), Ν (%) | Healthy control subjects (Ν = 53), Ν (%) | p-Value | |
| Gender | Male | 162 (54.2) | 137 (55.7) | 25 (47.2) | 0.0001 |
| Female | 137 (45.8) | 109 (44.3) | 28 (52.8) | ||
| Age (years) (64.12 ± 14.77)1 | 18-44 | 30 (9.8) | 14 (5.7) | 31 (58.5) | 0.0001 |
| 45-60 | 72 (23.6) | 71 (28.7) | 13 (24.5) | ||
| 60-75 | 132 (43.3) | 87 (35.2) | 5 (9.4) | ||
| 75+ | 71 (23.3) | 75 (30.4) | 4 (7.5) | ||
| Place of residence | Urban area | 104 (34.7) | 78 (31.6) | 26 (49.1) | 0.011 |
| Rural area | 195 (65.0) | 168 (68.0) | 27 (50.9) |
Eating habits of patients and controls (by category and their relative calculated total AGEs)
AGEs, advanced glycation end products
*Mean ± standard deviation
1: pieces; 2: portions; 3: tablespoons
| Patients (Ν = 305)* | Control subjects (Ν = 247)* | Healthy control subjects (Ν = 53)* | p-Value | |||
| Fruits1 per week | 10.15 ± 9.29 | 11.73 ± 7.60 | 24.62 ± 16.35 | 0.0001 | ||
| Total AGEs | 10.15 ± 9.29 | 11.73 ± 7.60 | 24.62 ± 16.35 | 0.0001 | ||
| Vegetables2 per week | 13.41 ± 7.47 | 15.54 ± 7.19 | 22.43 ± 10.46 | 0.0001 | ||
| Total AGEs | 178.45 ± 171.77 | 145.58 ± 104.41 | 153.02 ± 109.74 | 0.893 | ||
| Dairy products2 per week | 11.52 ± 6.95 | 9.32 ± 6.45 | 10.75 ± 6.81 | 0.0001 | ||
| Total AGEs | 2310.49 ± 4216.78 | 1063.94 ± 1973.99 | 3177.70 ± 4806.77 | 0.003 | ||
| Starch2 per week | 21.85 ± 11.79 | 22.78 ± 13.51 | 19.02 ± 2.97 | 0.005 | ||
| Total AGEs | 121.75 ± 80.31 | 85.96 ± 72.41 | 55.53 ± 51.20 | 0.0001 | ||
| Meat/fish2 per week | 18.49 ± 10.49 | 4.12 ± 1.95 | 8.79 ± 7.92 | 0.0001 | ||
| Total AGEs | 1827.97 ± 1046.34 | 403.36 ± 185.59 | 833.39 ± 757.25 | 0.0001 | ||
| Cold cuts1 per week | 0.18 ± 0.81 | 0.32 ± 1.03 | 1.28 ± 1.97 | 0.0001 | ||
| Total AGEs | 0.06 ± 0.24 | 0.14 ± 0.40 | 0.46 ± 0.61 | 0.0001 | ||
| Sauces3 (mustard, mayonnaise, ketchup, etc.) per week | 0.01 ± 0.11 | 0.02 ± 0.15 | 0.02 ± 0.19 | 0.054 | ||
| Total AGEs | 98.03 ± 140.80 | 208.29 ± 162.33 | 132.17 ± 158.99 | 0.0001 | ||
| Sweets1 per week | 3.12 ± 2.79 | 7.43 ± 11.94 | 22.02 ± 24.81 | 0.0001 | ||
| Total AGEs | 16.78 ± 18.33 | 7.43 ± 11.94 | 22.02 ± 24.81 | 0.0001 | ||
| Snacks1 (cookies, crisps, nuts, cereals, etc.) per week | 3.61 ± 4.28 | 3.21 ± 3.90 | 10.77 ± 11.07 | 0.0001 | ||
| Total AGEs | 50.76 ± 85.98 | 82.61 ± 149.89 | 140.85 ± 155.62 | 0.0001 | ||
| Fast food2 per week | 2.59 ± 3.35 | 2.75 ± 3.20 | 4.92 ± 6.85 | 0.018 | ||
| Total AGEs | 259.01 ± 335.10 | 274.90 ± 320.47 | 492.45 ± 685.24 | 0.018 | ||
| Canned food1 per week | 0.27 ± 1.07 | 0.15 ± 0.48 | 0.38 ± 1.00 | 0.048 | ||
| Total AGEs | 2.25 ± 7.92 | 2.18 ± 13.46 | 6.32 ± 30.66 | 0.056 | ||
| Drinks2 per week | 12.76 ± 6.46 | 12.32 ± 5.81 | 15.47 ± 7.52 | 0.015 | ||
| Total AGEs | 12.76 ± 6.46 | 12.32 ± 5.81 | 15.47 ± 7.52 | 0.015 | ||
| Alcoholic beverage2 per week | 4.01 ± 4.99 | 4.09 ± 5.66 | 4.22 ± 5.90 | 0.568 | ||
| Total AGEs | 4.01 ± 4.99 | 4.09 ± 5.66 | 4.22 ± 5.90 | 0.568 | ||
| Raw olive oil3 per week | 22.2 ± 16.93 | 28.97 ± 19.83 | 21.4 1 ± 13.83 | 0.0001 | ||
| Total AGEs | 222.00 ± 169.37 | 289.79 ± 198.36 | 214.15 ± 138.35 | 0.0001 | ||
| Total AGEs | 5271.28 ± 5087.77 | 2786.16 ± 2511.88 | 5736.07 ± 5917.81 | 0.0001 | ||
Hematological/biochemical markers of patients and control subjects
SD, standard deviation; ΗbA1c, glycated hemoglobin; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; LDL, low-density lipoprotein; HDL, high-density lipoprotein
1. Mean ± standard deviation
| Patients (Ν = 305) | Control subjects (Ν = 247) | Healthy control subjects (Ν = 53) | ||
| COMPLETE BLOOD COUNT | Mean ± SD1 | Mean ± SD1 | Mean ± SD1 | p-Value |
| Red blood cells (*103/mm3) | 3975.77 ± 911.06 | 4573.62 ± 778.97 | 4622.62 ± 728.35 | 0.0001 |
| White blood cells (*103/mm3) | 7240.95 ± 2179.80 | 7506.11 ± 2294.16 | 6957.92 ± 2620.32 | 0.083 |
| Platelets (*103/mm3) | 204.82 ± 69.59 | 244.35 ± 76.80 | 229.73 ± 74.11 | 0.0001 |
| Hematocrit (%) | 35.37 ± 3.48 | 39.63 ± 5.23 | 40.18 ± 3.74 | 0.0001 |
| Hemoglobin (g/dL) | 11.43 ± 1.21 | 13.85 ± 1.61 | 13.35 ± 1.48 | 0.0001 |
| RENAL FUNCTION MARKERS | Mean ± SD1 | Mean ± SD1 | Mean ± SD1 | p-Value |
| Urea (mg/dL) | 153.07 ± 44.21 | 48.03 ± 28.61 | 27.60 ± 9.42 | 0.0001 |
| Creatinine (mg/dL) | 8.07 ± 2.54 | 1.11 ± 0.56 | 0.73 ± 0.31 | 0.0001 |
| Uric acid (mg/dL) | 6.05 ± 1.34 | 5.89 ± 1.87 | 4.61 ± 0.98 | 0.0001 |
| GLYCEMIC MARKERS | Mean ± SD1 | Mean ± SD1 | Mean ± SD1 | p-Value |
| Fasting blood glucose (mg/dL) | 125.62 ± 62.17 | 156.77 ± 65.51 | 92.32 ± 12.28 | 0.0001 |
| ΗbA1c (%) | 6.12 ± 1.42 | 6.98 ± 1.32 | 5.00 ± 0.52 | 0.0001 |
| INFLAMMATORY MARKERS | Mean ± SD1 | Mean ± SD1 | Mean ± SD1 | p-Value |
| CRP (mg/dL) | 4.21 ± 6.96 | 2.14 ± 1.17 | 1.55 ± 1.34 | 0.446 |
| ESR (mm/h) | 39.07 ± 25.12 | 25.78 ± 14.22 | 13.00 ± 11.01 | 0.005 |
| Ferritin (ng/mL) | 305.43 ± 242.98 | 277.34 ± 184.69 | 59.93 ± 53.41 | 0.002 |
| LIPIDEMIC MARKERS | Mean ± SD1 | Mean ± SD1 | Mean ± SD1 | p-Value |
| Total cholesterol (mg/dL) | 162.92 ± 43.78 | 178.74 ± 57.53 | 151.40 ± 51.55 | 0.0001 |
| LDL cholesterol (mg/dL) | 86.22 ± 33.05 | 106.69 ± 34.09 | 99.25 ± 24.29 | 0.0001 |
| HDL cholesterol (mg/dL) | 48.33 ± 15.74 | 50.82 ± 17.31 | 58.90 ± 12.64 | 0.0001 |
| Triglycerides (mg/dL) | 185.75 ± 106.58 | 159.92 ± 98.10 | 92.70 ± 43.86 | 0.0001 |
| ELECTROLYTES | Mean ± SD1 | Mean ± SD1 | Mean ± SD1 | p-Value |
| Sodium (mmol/L) | 139.95 ± 2.16 | 140.01 ± 2.25 | 139.71 ± 2.88 | 0.0001 |
| Potassium (mmol/L) | 5.14 ± 0.71 | 4.70 ± 0.59 | 4.41 ± 0.41 | 0.0001 |
| Calcium (mmol/L) | 9.01 ± 0.89 | 9.82 ± 1.37 | 9.56 ± 0.25 | 0.0001 |
| Phosphorus (mmol/L) | 5.06 ± 1.37 | 4.18 ± 2.04 | 3.55 ± 0.92 | 0.0001 |
Somatometric characteristics of patients and control subjects
1. Mean ± standard deviation
| Somatometric characteristics | Patients (Ν = 305)1 | Control subjects (Ν = 247)1 | Healthy control subjects (Ν = 53)1 | p-Value |
| Body mass index (kg/m2) | 26.50 ± 4.84 | 30.02 ± 4.85 | 27.09 ± 4.21 | 0.0001 |
| Waist circumference (cm) | 90.58 ± 17.66 | 99.22 ± 14.22 | 89.94 ± 15.78 | 0.0001 |